Condensed Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,553,416	$ 2,329,218
Inventory	4,600,618
Prepaid expenses	583,339	759,292
Deferred financing costs		408,000
Other current assets	14,638	20,188
Total current assets	6,752,011	3,516,698
Property and equipment, net	54,273	214,578
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	194,725	245,683
Total assets	14,648,276	11,624,226
Current liabilities:
Accounts payable	5,713,655	3,813,280
Accrued expenses	4,724,835	3,657,394
Deferred collaboration funding, current	181,888	8,412,971
Schelling Promissory Note payable to an officer	1,000,000
Other current liabilities	742,922	741,425
Convertible note payable, current, at fair value	13,078,200
SWK Loans payable, current, at fair value	17,986,848	2,326,630
Total current liabilities	43,428,348	18,951,700
Deferred collaboration funding, non-current	4,365,310
SWK Loans payable, non-current, at fair value		3,240,601
Convertible note payable, at fair value		6,047,532
Other non-current liabilities	100,836	145,665
Total liabilities	47,894,494	28,385,498
Commitments and Contingencies (Note 8)
Stockholders’ deficit:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 23,421,534 and 19,624,280 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	2,446	1,962
Additional paid-in capital	131,870,031	123,984,035
Accumulated deficit	(165,118,695)	(140,747,269)
Total stockholders’ deficit	(33,246,218)	(16,761,272)
Total liabilities and stockholders’ deficit	$ 14,648,276	$ 11,624,226